GDF15, due to its sensitivity to metabolic signals and its function in inhibiting tumor-promoting stromal dynamics, presents a valuable molecular target for comprehensive therapeutic approaches, especially in individuals with metabolic comorbidities like diabetes [102]. The gene discussed is GDF15; the disease is neoplasm.